Allarity Therapeutics, Inc. (ALLR)
USD 0.97
(-11.81%)
USD 0.97
(-11.81%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Operating Cash Flow | -12.74 Million | -16.81 Million | -15.05 Million | -7.25 Million | -10.11 Million |
| Net Income | -11.9 Million | -16.05 Million | -26.64 Million | -5.07 Million | -14.4 Million |
| Depreciation & Amortization | 37 Thousand | 60 Thousand | 106 Thousand | 46 Thousand | 51 Thousand |
| Deferred income taxes | 97 Thousand | -1.61 Million | 20 Thousand | -1.28 Million | -3.76 Million |
| Stock-based compensation | -71 Thousand | 1.75 Million | 6.36 Million | 616 Thousand | 333 Thousand |
| Change in working capital | 3.35 Million | -328 Thousand | 5.57 Million | 445 Thousand | 2.06 Million |
| Other non-cash items | -4.25 Million | -631 Thousand | -466 Thousand | -1.99 Million | 5.6 Million |
| Investing Cash Flow | - | 791 Thousand | 1 Million | -3000.00 | 229 Thousand |
| Investments in PPE | - | -18 Thousand | - | -3000.00 | -8000.00 |
| Acquisitions | - | - | - | - | - |
| Investment purchases | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | 237 Thousand |
| Other Investing Activities | - | 809 Thousand | 1 Million | - | - |
| Financing Cash Flow | 10.99 Million | -1.31 Million | 33.81 Million | 6.03 Million | 11.2 Million |
| Debt repayment | -2.64 Million | -1 Million | -2.94 Million | -533 Thousand | -5.1 Million |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | -6.65 Million | -1.51 Million | - | - | - |
| Common Stock Issuance | 20.29 Million | - | 32.12 Million | 3.7 Million | 13.55 Million |
| Other Financing Activities | 10.99 Million | 1.2 Million | 4.63 Million | 2.86 Million | 2.75 Million |
| Accounts receivables | -26 Thousand | - | - | 95 Thousand | -95 Thousand |
| Accounts payables | 2.16 Million | 6.2 Million | -1.31 Million | -62 Thousand | 237 Thousand |
| Inventory | - | - | - | - | 1.96 Million |
| Other working capital | 1.21 Million | -6.53 Million | 6.88 Million | 412 Thousand | -47 Thousand |
| Cash at beginning of period | 2.02 Million | 19.55 Million | 298 Thousand | 1.52 Million | 237 Thousand |
| Cash at end of period | 166 Thousand | 2.02 Million | 19.55 Million | 298 Thousand | 1.52 Million |
| Capital Expenditure | - | -18 Thousand | - | -3000.00 | -8000.00 |
| Effect of forex changes on cash | -113 Thousand | -189 Thousand | -512 Thousand | -5000.00 | -31 Thousand |
| Net cash flow / Change in cash | -1.86 Million | -17.52 Million | 19.25 Million | -1.22 Million | 1.28 Million |
| Free Cash Flow | -12.74 Million | -16.83 Million | -15.05 Million | -7.25 Million | -10.12 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.62 Million | -3.84 Million | -11.9 Million | -1.72 Million | -4.44 Million | -2.38 Million |
| Depreciation & Amortization | 1000.00 | 2000.00 | 37 Thousand | 9000.00 | 9000.00 | 9000.00 |
| Deferred income taxes | - | -14 Thousand | 97 Thousand | 97 Thousand | -10 Thousand | -1.91 Million |
| Stock-based compensation | 111 Thousand | -121 Thousand | -71 Thousand | -254 Thousand | 124 Thousand | 180 Thousand |
| Change in working capital | -3.57 Million | 2.88 Million | 3.35 Million | 3.47 Million | -1.81 Million | 1.11 Million |
| Other non-cash items | 1.64 Million | -2.83 Million | -4.25 Million | -3.28 Million | 764 Thousand | 489 Thousand |
| Investing Cash Flow | - | - | - | 116 Thousand | - | -116 Thousand |
| Investments in PPE | - | - | - | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | 116 Thousand | - | - |
| Financing Cash Flow | 26.3 Million | 1.38 Million | 10.99 Million | 522 Thousand | 6.45 Million | 2.86 Million |
| Debt repayment | -1.34 Million | -1.34 Million | -2.64 Million | -1.72 Million | -1.37 Million | -2.29 Million |
| Dividends payments | - | -228 Thousand | - | - | - | - |
| Common Stock Repurchased | - | - | -6.65 Million | 6.65 Million | -5 Million | -1.65 Million |
| Common Stock Issuance | 27.64 Million | 40 Thousand | 20.29 Million | 2.24 Million | 10.08 Million | 6.81 Million |
| Other Financing Activities | - | 1.6 Million | 10.99 Million | 14.57 Million | - | - |
| Accounts receivables | -248 Thousand | -516 Thousand | -26 Thousand | 748 Thousand | -12 Thousand | -739 Thousand |
| Accounts payables | -3.41 Million | 2.83 Million | 2.16 Million | 2.06 Million | -1.74 Million | 1.64 Million |
| Inventory | - | - | - | -1.34 Million | 12 Thousand | 739 Thousand |
| Other working capital | 84 Thousand | 566 Thousand | 1.21 Million | 661 Thousand | -74 Thousand | -521 Thousand |
| Cash at beginning of period | 312 Thousand | 166 Thousand | 2.02 Million | 1.39 Million | 420 Thousand | 295 Thousand |
| Cash at end of period | 19.23 Million | 312 Thousand | 166 Thousand | 166 Thousand | 1.39 Million | 420 Thousand |
| Capital Expenditure | - | - | - | - | - | - |
| Effect of forex changes on cash | -172 Thousand | 253 Thousand | -113 Thousand | -83 Thousand | -95 Thousand | -244 Thousand |
| Net cash flow / Change in cash | 18.92 Million | 146 Thousand | -1.86 Million | -1.23 Million | 979 Thousand | 125 Thousand |
| Free Cash Flow | -7.21 Million | -1.48 Million | -12.74 Million | -1.67 Million | -5.37 Million | -2.49 Million |
TRAD
PREC
ATLX
SYNACT
RAIL
ANNX